Your browser doesn't support javascript.
loading
Identification and tracking of Addictovigilance signals in general practice: which interactions between the general practitioners and the French Addictovigilance Network?
Gentile, Gaétan; Jego, Maeva; Spadari, Michel; Griffiths, Karolina; Jouanjus, Emilie; Micallef, Joëlle.
Afiliação
  • Gentile G; Département Universitaire de Médecine Générale, Faculté de Médecine, Aix Marseille Université, 27 boulevard Jean Moulin, Marseille, 13385, France.
  • Jego M; Institut des Neurosciences des Systèmes, INSERM 1106, Aix Marseille Université, INSERM, INS, Inst Neurosci Syst, Faculté Médecine Timone, 27 Bd Jean Moulin, 133855, Marseille, France.
  • Spadari M; Département Universitaire de Médecine Générale, Faculté de Médecine, Aix Marseille Université, 27 boulevard Jean Moulin, Marseille, 13385, France.
  • Griffiths K; EA 3279 Research Unit-Public Health, Chronic Diseases and Quality of Life, Aix-Marseille University, CERESS, EA3279, 27 Bd Jean Moulin, Marseille, 13385, France.
  • Jouanjus E; Institut des Neurosciences des Systèmes, INSERM 1106, Aix Marseille Université, INSERM, INS, Inst Neurosci Syst, Faculté Médecine Timone, 27 Bd Jean Moulin, 133855, Marseille, France.
  • Micallef J; CEIP-Addictovigilance PACA Corse, Service de Pharmacologie Clinique et Pharmacovigilance, AP-HM, Marseille, 13385, France.
Fundam Clin Pharmacol ; 32(6): 643-651, 2018 Dec.
Article em En | MEDLINE | ID: mdl-30003596
ABSTRACT
Addictovigilance is a health vigilance dedicated to the survey of medicinal or illicit psychoactive substance use disorders (SUDs). France is the only European country to have a vigilance system specifically dedicated to substances with an abuse/addiction potential. The French Addictovigilance system is organized in a network of regional tertiary centres (called Abuse and Dependence Monitoring Centres, CEIP-Addictovigilance) and works in close collaboration with Regional and National health authorities. Because of the essential and unavoidable nature of their practice in the French Healthcare system, general practitioners (GPs) are key actors to identify and track Addictovigilance signals. They have been involved in several of the pharmacoepidemiological surveys implemented by the French Addictovigilance Network (FAN). Now, they increasingly participate in clinical research projects and studies. In this article, interactions between GPs and the FAN are illustrated with two examples patients on opioid substitution treatment and patients on opioid analgesics. Collaborations between GPs and the FAN could be further potentiated. In particular, more effective communication on psychoactive SUDs including abuse/addiction is necessary to optimize the implementation of preventive measures for patients on psychoactive substances medications, and to improve the attitudes of GPs and more widely health professionals in the management of any psychoactive user suffering from SUDs. In addition, both adapted training and improved collaborative research could contribute to the optimization (safety, quality) of professional practices.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psicotrópicos / Transtornos Relacionados ao Uso de Substâncias Tipo de estudo: Diagnostic_studies Limite: Female / Humans País como assunto: Europa Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psicotrópicos / Transtornos Relacionados ao Uso de Substâncias Tipo de estudo: Diagnostic_studies Limite: Female / Humans País como assunto: Europa Idioma: En Ano de publicação: 2018 Tipo de documento: Article